Profile
Stiris is a clinical trial management company conducting Phase I-IIIB trials for biotech and biopharma. Located in Cambridge, MA, USA, and Ontario, Canada, Stiris has a unique opportunity to tap into funding for our non-Canadian clients. It is the only contract research organization formed from listening to stakeholders engaged in clinical trials, identifying their unmet needs, and developing a unique, value-based approach to address those needs. Stiris was built by biotech, for biotech.
Website
stirisresearch.comContact
-
Shantal Feltham, President and Chief Executive OfficerTel: +1 519-652-5327Email: shantal@stirisresearch.com
-
-
-
-
-
Event details
Name: Ontario at BIO 2025
Date: June 16 - 19, 2025
Event contact
Patricia Cosgrove
Area Director
USA: Life Sciences
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
23 in total
-
20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for… -
Since 2001, BioScript Solutions has supported patients with chronic illnesses and rare diseases by providing… -
Custom Biologics provides regulatory compliant potency testing and assay services for all phases of… -
Dalriada is a leading North American discovery company pioneering its novel Turn-Key™ model in small molecule… -
HDAX Therapeutics, a biotechnology company pioneering a novel approach to target HDAC6 to address… -
ImmunoBiochem is an innovative biopharmaceutical company developing novel bioconjugate therapeutics, such … -
Invest Ontario is a provincial agency dedicated to securing private sector strategic business and capital… -
Raising capital is a key challenge for executives at early-stage therapeutics companies. Lumerate is launching… -
mDETECT offers highly sensitive and cost-effective blood tests that can measure tumour behaviour irrespective of… -
Noa Therapeutics is a preclinical biotech company pioneering the development of homeostatic modulating small… -
Nucro-Technics is a full-service Contract Support Organization that specializes in the conduct of both GLP… -
Paradox Immunotherapeutics is a biotech addressing the global burden of protein misfolding diseases—devastating… -
ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead… -
QReserve provides powerful enterprise-grade scheduling and resource management software to world-class… -
Specific Biologics is developing Dualase®, an industry-leading genome editing platform with best-in-class… -
Spiderwort is a platform biomaterials company developing a suite of cellulose-based scaffolds for use in a number… -
Stiris is a clinical trial management company conducting Phase I-IIIB trials for biotech and… -
Sussex Research Laboratories Inc. (Ottawa, Canada) is recognized as a leader in the design and synthesis of… -
SYNG Pharma is developing a new first-in-class diagnostic test and non-hormonal therapy for endometriosis. The… -
Transpharmation is a contract research organisation led by scientists. Recognised by drug developers worldwide… -
VeriLuce Therapeutics is an early-stage drug company developing novel small molecules targeting in dual… -
Virano is a genetic immunomodulation company, developing next-generation combination products which reprogram the… -
YYZ Pharmatech Inc. (“YYZ”) is a deep tech company endeavoring to profoundly progress…